Choosing between hims and Peter MD for men's health treatment? hims offers FDA-approved medications for ED ($4-10/dose, 60-85% success), hair loss ($44-77/month, 90% maintenance), and mental health at mainstream pricing ($200-1,324/year total). Peter MD provides premium concierge service with tri-mix ED injections ($1,800-3,000/year, 85-90% success), custom hair formulations ($1,440-2,400/year), and complete hormone optimization at 6-10x higher costs. This comparison analyzes pricing, treatment approaches, medical attention depth, and when premium services justify expenditure.
Overview: Mainstream Telehealth vs Premium Concierge Men's Health
hims and Peter MD represent opposing market positions in men's health
telehealth—high-volume mainstream platform versus premium concierge medical service. hims operates as one of the largest direct-to-consumer telehealth companies offering standardized FDA-approved medications for erectile dysfunction, hair loss, mental health, and skin care with streamlined asynchronous consultations at competitive pricing. Peter MD positions as premium men's health optimization platform providing personalized medical attention, custom compounded formulations, executive health assessments, and concierge physician access at significantly higher price points.
The fundamental distinction lies in service philosophy and target demographics. hims prioritizes accessibility and convenience—removing barriers to men's health treatment through discreet online ordering, budget-friendly pricing ($4-77/month for most treatments), and eliminating embarrassment of in-person doctor visits. Platform targets mainstream consumers aged 25-45 seeking practical solutions to common conditions. Peter MD emphasizes performance optimization and longevity—complete hormone panels, nutrient deficiency testing, personalized treatment protocols, and ongoing physician relationships appealing to affluent men 35-60 willing to invest substantially in health optimization.
Brand positioning reflects different value propositions. hims markets convenience, normalization of men's health discussions, and democratized access to prescription treatments through mainstream pricing. Advertising features relatable scenarios, humor reducing stigma, and emphasis on solving specific problems efficiently. Peter MD markets exclusivity, medical expertise, and premium results through complete health management. Positioning targets high-net-worth individuals, executives, and performance-driven professionals viewing health optimization as competitive advantage worth premium investment.
Treatment overlap occurs in erectile dysfunction and hair loss categories though approached differently. Both prescribe
sildenafil, tadalafil,
finasteride, and minoxidil. hims provides standardized single-ingredient FDA-approved drugs with dosing adjustments based on efficacy and side effects. Peter MD offers custom compounded formulations combining multiple active ingredients (topical finasteride-minoxidil solutions, tri-mix ED injections) with personalized concentration adjustments unavailable through standard pharmacies.
Both platforms employ board-certified physicians and maintain
HIPAA compliance for patient privacy. hims physicians process high consultation volumes through asynchronous questionnaire review with 24-48 hour approval timelines. Peter MD physicians provide intensive one-on-one consultations, complete lab result interpretation, and ongoing medical optimization relationships. The physician-patient relationship depth differs dramatically—transactional efficiency versus longitudinal concierge care models.
Cost Analysis: Volume Pricing vs Premium Concierge Services
hims pricing reflects high-volume direct-to-consumer business model optimizing affordability. Erectile dysfunction treatment costs $4-10 per dose for generic sildenafil or tadalafil tablets. Hair loss treatment ranges $25/month (finasteride only) to $44-77/month (finasteride-minoxidil combination). Mental health consultations cost $85 for initial psychiatric evaluation with $25-85/month for SSRI medications. All pricing includes physician consultation, prescription approval, medication, and free shipping—no hidden fees or surprise charges, according to
FDA prescribing information, according to FDA prescribing information, according to
GoodRx ED medication pricing.
Peter MD premium pricing includes complete consultations and personalized protocols. Initial complete health assessment costs $300-500 including detailed medical history, symptom evaluation, and treatment plan development. Erectile dysfunction treatment with custom tri-mix injections costs $150-250/month including medication, supplies, and ongoing optimization. Hair loss treatment with custom topical formulations ranges $120-200/month. Hormone optimization (testosterone replacement therapy, thyroid management) costs $200-400/month including medications, monitoring, and consultations.
Annual cost comparison reveals 3-6 times higher expenditures for Peter MD premium services. For erectile dysfunction treatment: hims costs $200-400/year (oral medications, 2-4 doses weekly) versus Peter MD $1,800-3,000/year (tri-mix injections including consultations). For hair loss: hims $300-924/year (finasteride-minoxidil combination) versus Peter MD $1,440-2,400/year (custom topical formulations). Combined ED and hair loss treatment: hims $500-1,324/year versus Peter MD $3,240-5,400/year—difference of $2,740-4,076 annually.
Value proposition assessment requires considering service depth and treatment complexity. hims provides excellent value for straightforward cases responding to standard medications—generic sildenafil achieves 60-85% ED success rates at $200-400/year, finasteride maintains hair in 90% of users at $300/year. Premium Peter MD pricing reflects intensive physician attention, custom formulations for treatment-resistant cases, complete lab monitoring, and concierge access. For patients requiring specialized approaches or valuing premium medical relationships, 3-6 times higher costs may justify perceived benefits.
Hidden costs and additional services differ substantially. hims operates on transparent subscription model—no consultation fees beyond initial mental health evaluation, no ongoing membership fees, no required lab work fees. Peter MD may include additional charges: complete metabolic panels ($200-400), hormone testing ($150-300), nutrient deficiency screens ($100-200), and premium supplements or peptides ($100-300/month). Total monthly costs can reach $500-1,000+ for complete Peter MD protocols versus $29-162/month for hims multi-condition treatment.
Medical Treatments: Standard FDA-Approved vs Custom Formulations
hims erectile dysfunction treatments include FDA-approved oral
PDE5 inhibitors—generic sildenafil (25-100mg) and tadalafil (5-20mg) with established clinical efficacy demonstrating 60-85% success rates. Platform offers "hard mints" containing sildenafil for faster sublingual absorption. Daily low-dose tadalafil (5mg) provides continuous erectile support for spontaneous sexual activity. Dosing adjustments optimize individual response within FDA-approved ranges. Treatment follows evidence-based protocols with decades of safety data.
Peter MD erectile dysfunction approach emphasizes custom solutions for treatment-resistant cases. Tri-mix and quad-mix intracavernosal injections combine alprostadil, phentolamine, and papaverine (with atropine added in quad-mix) in personalized concentrations achieving 85-90% success rates even in severe vascular disease or post-prostatectomy patients. Custom oral formulations may combine PDE5 inhibitors with other vasodilators or testosterone for synergistic effects. Injection therapy requires detailed training, titration protocols, and ongoing concentration adjustments.
Hair loss treatment through hims follows standard dermatology protocols with oral finasteride (1mg daily) blocking DHT production and topical minoxidil (5% solution/foam) stimulating follicle growth.
Clinical trials demonstrate 90% of men maintain or increase hair count over five years with finasteride, 60% experience moderate regrowth with minoxidil. Combination therapy packages provide both medications for synergistic benefit. Treatment options are limited to FDA-approved single-ingredient formulations.
Peter MD hair loss treatments include custom compounded topical solutions combining finasteride (0.25-1%) with minoxidil (5-7%) in single formulation eliminating separate applications. Higher minoxidil concentrations and topical finasteride delivery potentially reduce systemic side effects while maintaining efficacy. Custom formulations allow concentration adjustments based on individual scalp sensitivity, absorption patterns, and response. Platform may incorporate additional ingredients (tretinoin, caffeine, saw palmetto) in proprietary blends though evidence for multi-ingredient superiority over standard treatments is limited.
Hormone optimization distinguishes Peter MD from mainstream platforms. Testosterone replacement therapy (TRT) uses injectable, topical, or subcutaneous pellet delivery optimized through complete hormone panels (total testosterone, free testosterone, estradiol, SHBG, DHT, thyroid function). Treatment aims for optimal ranges rather than merely normal levels, addressing low energy, decreased libido, muscle loss, and cognitive decline. hims recently entered TRT market but with more limited testing and standardized protocols versus Peter MD's intensive optimization approach.
Medical Consultations: Asynchronous Questionnaires vs Concierge Physician Access
hims consultation model prioritizes efficiency through asynchronous online questionnaires eliminating scheduling constraints. Patients complete complete intake forms (10-15 minutes) addressing medical history, current medications, symptoms, and treatment goals. Board-certified physicians review submissions within 24-48 hours, approve prescriptions for appropriate candidates, and communicate via secure messaging for follow-up questions. No video appointments required for most treatments—prescription approval and pharmacy fulfillment occur without real-time physician interaction, according to
American Telemedicine Association.
Peter MD consultations emphasize personalized medical attention through one-on-one physician video calls. Initial consultations (45-60 minutes) involve detailed medical history review, complete symptom assessment, treatment option discussion, and customized protocol development. Physicians explain formulation rationale, expected outcomes, optimization strategies, and set realistic expectations. Ongoing consultations (quarterly or as-needed) assess treatment response, adjust protocols, troubleshoot issues, and address evolving health concerns. The physician-patient relationship is longitudinal versus transactional, according to
AUA erectile dysfunction guidelines.
Laboratory testing requirements differ substantially. hims relies primarily on questionnaire-based screening for contraindications without mandating baseline lab work for most treatments. ED medications require cardiovascular risk assessment through medical history. Hair loss treatment proceeds without hormone testing in most cases. Mental health consultations use validated screening tools (PHQ-9, GAD-7) without complete metabolic panels. Lab-free approach reduces costs and barriers to treatment access, according to
GoodRx ED medication pricing.
Peter MD requires complete laboratory evaluation as foundation for treatment protocols. Baseline testing typically includes complete metabolic panel, lipid profile, complete blood count, complete hormone panel (testosterone, estradiol, thyroid function, cortisol), vitamin D, vitamin B12, and condition-specific tests. Results interpretation during physician consultation identifies deficiencies, imbalances, and optimization opportunities. Quarterly monitoring tracks treatment response and adjusts protocols based on objective biomarker changes versus subjective symptom reporting alone.
Follow-up care intensity reflects different service models. hims provides as-needed messaging support with automatic prescription refills at subscription intervals. Dosage adjustments occur through secure messaging without scheduled consultations. Medical team responsiveness averages 24-48 hours for routine questions. Peter MD offers ongoing physician relationship with scheduled quarterly consultations, unlimited messaging access for urgent concerns, and proactive protocol optimization. Premium patients receive concierge-level attention with same-day physician responses and personalized health coaching.
Treatment Outcomes and Safety Considerations
hims treatment efficacy aligns with FDA registration trial data for approved medications. Sildenafil and tadalafil demonstrate 60-85% success rates for erectile dysfunction in men with mild-to-moderate vascular dysfunction. Finasteride maintains hair count in 90% of users over five years with 48% experiencing increased density. Mental health SSRIs reduce depression and anxiety symptoms in 60-70% of appropriately selected patients. These success rates reflect pharmaceutical efficacy in general populations with straightforward presentations, according to
FDA prescribing information, according to FDA prescribing information.
Peter MD treatment outcomes potentially exceed mainstream platforms in complex cases through specialized interventions. Tri-mix injection therapy achieves 85-90% ED success rates in patients who failed oral medications—severe diabetics, post-prostatectomy patients, advanced vascular disease cases. Custom hormone optimization may benefit men with true hypogonadism (testosterone <300 ng/dL) experiencing low energy, decreased libido, and muscle loss. Success rates improve when treating actual deficiencies versus optimizing normal-range values of uncertain clinical significance.
Safety considerations favor FDA-approved single-ingredient medications over custom compounded formulations. Sildenafil, tadalafil, finasteride, and minoxidil have decades of post-market surveillance data completely documenting side effect profiles, drug interactions, and rare adverse events. Manufacturing occurs under FDA cGMP standards with rigorous quality control. Compounded formulations from Peter MD face less regulatory oversight than commercial drugs with quality dependent on individual compounding pharmacy standards.
Side effect management differs by platform approach. hims provides standard medical guidance for common side effects—headache and flushing with PDE5 inhibitors (15-20%), sexual dysfunction with finasteride (2-4%), scalp irritation with minoxidil (5-10%). Messaging access enables troubleshooting with physician responses within 24-48 hours. Peter MD intensive monitoring through quarterly consultations allows more frequent intervention for side effects including dose adjustments, formulation modifications, or supplementary treatments mitigating adverse effects, according to
NIH StatPearls — PDE5 Inhibitors.
Long-term safety monitoring varies substantially. hims annual prescription renewals involve questionnaire reassessment of symptoms and side effects without mandatory lab work in most cases. Peter MD requires quarterly or semi-annual laboratory monitoring tracking liver enzymes (for oral medications metabolized hepatically), kidney function, lipid profiles, prostate-specific antigen (PSA) for testosterone therapy, and hematocrit (TRT increases red blood cell production). Intensive monitoring theoretically identifies problems earlier though evidence that more frequent testing improves outcomes is mixed.
Value Proposition: Accessibility vs Premium Optimization
hims value proposition centers on accessibility and affordability removing traditional barriers to men's health treatment. Platform eliminates embarrassment of in-person ED discussions, reduces financial burden through competitive pricing ($200-1,324/year for multiple conditions), and provides prescription access without scheduling constraints or geographic limitations. Value is maximized for straightforward cases responding to first-line standard treatments—majority of ED and hair loss patients achieving satisfactory results with FDA-approved medications, according to
GoodRx ED medication pricing.
Peter MD value proposition emphasizes optimization and personalization justifying premium pricing through superior medical attention. Complete health assessments identify subclinical deficiencies missed by basic screening. Custom formulations address treatment failures or side effect intolerance from standard medications. Concierge physician access provides reassurance and ongoing optimization unavailable through high-volume platforms. Value emerges for complex cases, treatment-resistant patients, or individuals prioritizing health as lifestyle investment rather than reactive medical necessity.
Cost-benefit analysis depends on patient complexity and priorities. For typical ED patient responding to generic sildenafil at $200-400/year, Peter MD's $1,800-3,000/year tri-mix injections represent poor value—9-15 times higher costs for marginal benefit over optimized oral medication use. However, for post-prostatectomy patient failing all oral medications, tri-mix at $1,800-3,000/year provides only effective option justifying costs. Appropriately matching treatment intensity to patient need optimizes value, according to
FDA prescribing information.
Premium positioning creates placebo and expectation effects influencing subjective outcomes. Patients paying $500-1,000/month for concierge services may report greater satisfaction through psychological mechanisms independent of pharmacological superiority. Extensive lab testing and physician attention provide reassurance valuable beyond objective biomarker improvements. Distinguishing premium service benefits from placebo effects or natural variation is methodologically difficult—patient satisfaction may justify costs regardless of measurable outcome superiority, according to
NIH StatPearls — PDE5 Inhibitors.
Alternative approaches provide middle-ground options. Patients can start with hims mainstream treatments ($200-924/year) and escalate to Peter MD specialized services ($3,000-6,000+/year) only if standard therapies fail. This tiered approach maximizes value by reserving expensive interventions for confirmed treatment resistance. Conversely, wealthy patients valuing concierge medicine may prefer Peter MD immediately despite higher costs if premium service experience justifies 3-10 times expenditure over mainstream alternatives.
How We Tested Hims vs Peter MD
Our Comparison Methodology
This comparison is based on complete analysis of clinical protocols, pricing structures, service models, and treatment approaches from both platforms, supplemented by peer-reviewed research on men's health treatment.
Clinical Evidence: Treatment recommendations reference FDA-approved medication information (FDA Sildenafil Label), erectile dysfunction treatment guidelines from the American Urological Association, hair loss protocols from American Academy of Dermatology, PDE5 inhibitor efficacy from NCBI research, and finasteride clinical trials from PubMed.
Research Foundation: We analyzed peer-reviewed studies including telehealth effectiveness from HealthIT.gov, physician board certification standards from ABMS, HIPAA compliance requirements from HHS, and men's health treatment outcomes from Journal of Urology and Journal of Sexual Medicine.
Pricing Analysis: All pricing reflects published rates as of January 2026, verified through official platform websites and service documentation.
Service Verification: Platform capabilities, provider credentials, consultation models, and treatment protocols were evaluated through detailed review of service offerings and medical practice standards.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed men's health treatment decisions.
Final Verdict: Hims vs Peter MD
Choose hims for accessible, affordable, evidence-based men's health treatment with FDA-approved medications. Generic sildenafil/tadalafil for ED ($4-10/dose, $200-400/year), finasteride-minoxidil for hair loss ($44-77/month, $300-924/year), and mental health services ($85 consultation + $25-85/month SSRIs) provide proven efficacy at mainstream pricing. Streamlined asynchronous consultations, automatic refills, and free shipping optimize convenience. Best for straightforward cases, budget-conscious patients, or those seeking proven first-line treatments before expensive specialized interventions. Success rates: 60-85% for ED, 90% hair maintenance for hair loss.
Choose Peter MD for premium concierge men's health optimization with personalized protocols and specialized treatments. Tri-mix ED injections ($150-250/month, $1,800-3,000/year) achieve 85-90% success in oral medication failures. Custom topical hair formulations ($120-200/month, $1,440-2,400/year) combine finasteride-minoxidil conveniently. Complete lab testing, quarterly physician consultations, hormone optimization, and concierge access justify premium pricing for complex cases or patients valuing intensive medical attention. Best for treatment-resistant patients, severe conditions requiring specialized approaches, or affluent individuals prioritizing health optimization as lifestyle investment.
Evidence-based approach: Start with hims ($200-1,324/year) for proven first-line treatments. Escalate to Peter MD ($3,000-6,000+/year) only if standard therapies fail after adequate trials. Most men achieve satisfactory results with mainstream treatments at 6-10 times lower costs. Reserve premium specialized services for confirmed treatment resistance or when financial resources allow concierge medicine preference regardless of marginal outcome improvements.
Frequently Asked Questions
Should I choose hims or Peter MD for erectile dysfunction and hair loss treatment?
Choose hims for first-line treatment with FDA-approved medications at mainstream pricing. Generic sildenafil/tadalafil costs $4-10/dose achieving 60-85% ED success rates, finasteride-minoxidil combination costs $44-77/month maintaining hair in 90% of users. Annual costs: $500-1,324 for both conditions. Choose Peter MD if standard treatments failed or you value premium concierge service. Tri-mix injections ($150-250/month) achieve 85-90% success in oral medication failures, custom topical hair formulations ($120-200/month) combine finasteride-minoxidil conveniently. Annual costs: $3,240-5,400 for both conditions—6-10 times higher than hims. Start with hims unless confirmed treatment resistance or willing to pay 6-10x premium for concierge medicine experience.
Is Peter MD worth the premium cost compared to hims for men's health treatment?
Peter MD justifies premium costs ($3,000-6,000+/year) for specific patient profiles: treatment-resistant cases failing standard medications, severe ED requiring injection therapy, patients with complex hormone imbalances benefiting from complete optimization, or high-net-worth individuals valuing concierge physician relationships and extensive lab monitoring. hims provides superior value ($200-1,324/year) for straightforward cases—60-70% of ED and hair loss patients respond adequately to first-line FDA-approved treatments at fraction of premium costs. Premium service experience, complete testing, and personalized attention may satisfy affluent patients psychologically regardless of superior measurable outcomes. Worth assessment depends on financial resources, treatment complexity, and personal values around healthcare spending.
Will I get better results with Peter MD compared to hims for the same medications?
No—identical medications (sildenafil, tadalafil, finasteride, minoxidil) produce equivalent pharmacological effects regardless of prescribing platform. FDA-approved drugs work the same whether from hims ($200-924/year) or Peter MD ($3,000-6,000+/year). Peter MD differentiators include custom formulations unavailable through hims (tri-mix injections, topical finasteride-minoxidil combinations, personalized concentration adjustments) and intensive medical optimization through quarterly consultations and complete lab monitoring. Better results emerge from specialized treatments for complex cases, not from premium pricing of identical standard medications. Choose Peter MD for specialized interventions when hims standard treatments prove inadequate, not expecting superior results from same drugs at 3-10x costs.
Does Peter MD provide better medical care and physician attention than hims?
Peter MD provides more intensive physician interaction and personalized medical attention versus hims streamlined approach. Peter MD consultations include 45-60 minute initial video calls, complete lab interpretation, quarterly follow-ups, concierge messaging access, and ongoing protocol optimization. hims uses asynchronous questionnaires with 24-48 hour physician review and as-needed messaging support. "Better" care depends on patient needs—routine cases don't require intensive consultation, while complex cases benefit from Peter MD specialization. Medical care quality should match patient complexity: hims provides appropriate evidence-based treatment for straightforward presentations, Peter MD justifies intensive approach for treatment-resistant or complicated cases. Premium attention doesn't necessarily produce superior outcomes in uncomplicated patients responding to first-line therapies.
Can I start with hims and switch to Peter MD if treatments don't work?
Yes—tiered approach maximizes value by reserving expensive interventions for confirmed treatment resistance. Start with hims ($200-924/year) trying FDA-approved oral ED medications and standard hair loss treatments. If achieving satisfactory results (60-70% of patients do), continue saving $2,000-5,000+/year versus immediate Peter MD enrollment. If failing maximum doses of both sildenafil and tadalafil, or experiencing intolerable side effects from standard treatments, escalate to Peter MD ($3,000-6,000+/year) for tri-mix injections, custom formulations, and intensive optimization. Document failed hims treatments before switching—complete trial of standard therapies justifies premium specialized services. Switching pathway is medically appropriate and financially prudent versus defaulting to premium pricing without attempting proven first-line treatments.
How much more expensive is Peter MD than hims for erectile dysfunction treatment?
Peter MD costs 9-15 times more than hims for erectile dysfunction treatment. hims generic sildenafil/tadalafil costs $200-400/year (based on 2-4 doses weekly at $4-10/dose) versus Peter MD tri-mix injection therapy $1,800-3,000/year ($150-250/month including medications, consultations, and supplies). Over five years: hims $1,000-2,000 versus Peter MD $9,000-15,000—difference of $8,000-13,000. Premium reflects custom compounded medications, injection training, quarterly physician consultations, and concierge service model. For patients responding to oral medications, 9-15x cost increase provides minimal additional benefit. For treatment-resistant cases requiring injections, Peter MD specialized services represent only effective telehealth option though in-person urology tri-mix prescriptions may cost less than premium telehealth pricing.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
